NCT02868918View on ClinicalTrials.gov

Evaluation of Biodentine Versus Glass Ionomer Cement in Treatment of Very Deep Carious Lesions

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

January 1, 2019

Study Completion Date

March 1, 2019

Conditions
Deep Caries
Interventions
DRUG

biodentine

tricalcium silicate cement used to replace the carious dentin

DRUG

glass ionomer cement

high viscosity glass ionomer used as a base material

DEVICE

DigoraH optium

digital Xray for follow up

Trial Locations (1)

02

Omnia Magdy, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT02868918 - Evaluation of Biodentine Versus Glass Ionomer Cement in Treatment of Very Deep Carious Lesions | Biotech Hunter | Biotech Hunter